IHE iShares U.S. Pharmaceuticals ETF
Issuer
IShares
Inception
May 1, 2006
AUM
$1.7B
Expense ratio
0.37%
Yield
1.30%
Asset class
Equity
Holdings
52
Last price
$109.92
The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.
+37.7%
2025-11-13low 80.25 · high 111.082026-11-13
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| IHE | +10.5% | +7.4% | +30.8% | +39.3% | +25.9% | +12.9% |
| Equity average (4725 funds) | -2.2% | -4.7% | +3008.3% | +1886.0% | +15.1% | +2.6% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$78K net.
Holdings · as of Nov 12, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | LLY ELI LILLY | 26.45% |
| 2 | JNJ JOHNSON & JOHNSON | 21.72% |
| 3 | VTRS VIATRIS | 4.90% |
| 4 | RPRX ROYALTY PHARMA PLC CLASS A | 4.78% |
| 5 | ZTS ZOETIS INC CLASS A | 4.66% |
| 6 | PFE PFIZER | 4.39% |
| 7 | MRK MERCK & CO INC | 4.13% |
| 8 | BMY BRISTOL MYERS SQUIBB | 4.04% |
| 9 | JAZZ JAZZ PHARMACEUTICALS PLC | 3.26% |
| 10 | ELAN ELANCO ANIMAL HEALTH | 2.68% |
| 11 | CORT CORCEPT THERAPEUTICS | 1.44% |
| 12 | AXSM AXSOME THERAPEUTICS | 1.35% |
| 13 | LGND LIGAND PHARMACEUTICALS | 1.28% |
| 14 | SUPN SUPERNUS | 1.24% |
| 15 | MANE VERADERMICS | 0.99% |
| 16 | DFTX DEFINIUM THERAPEUTICS INC | 0.94% |
| 17 | LQDA LIQUIDIA | 0.83% |
| 18 | AMRX AMNEAL PHARMACEUTICALS INC CLASS A | 0.81% |
| 19 | EWTX EDGEWISE THERAPEUTICS | 0.79% |
| 20 | OGN ORGANON | 0.74% |
| 21 | AMLX AMYLYX PHARMACEUTICALS | 0.66% |
| 22 | ELVN ENLIVEN THERAPEUTICS | 0.66% |
| 23 | XERS XERIS BIOPHARMA HOLDINGS | 0.61% |
| 24 | TARS TARSUS PHARMACEUTICALS | 0.60% |
| 25 | PRGO PERRIGO PLC | 0.47% |
| 26 | PBH PRESTIGE CONSUMER HEALTHCARE | 0.42% |
| 27 | TRVI TREVI THERAPEUTICS | 0.36% |
| 28 | MBX MBX BIOSCIENCES | 0.35% |
| 29 | HRMY HARMONY BIOSCIENCES HLDG | 0.34% |
| 30 | PCRX PACIRA BIOSCIENCES | 0.29% |
| 31 | ANIP ANI PHARMACEUTICALS | 0.29% |
| 32 | INVA INNOVIVA | 0.28% |
| 33 | MAZE MAZE THERAPEUTICS | 0.27% |
| 34 | OMER OMEROS | 0.27% |
| 35 | OCUL OCULAR THERAPEUTIX | 0.25% |
| 36 | RAPP RAPPORT THERAPEUTICS | 0.24% |
| 37 | SEPN SEPTERNA | 0.23% |
| 38 | NUVB NUVATION BIO CLASS A | 0.23% |
| 39 | LBRX LB PHARMACEUTICALS INC | 0.23% |
| 40 | HROW HARROW | 0.19% |
| 41 | AMPH AMPHASTAR PHARMACEUTICALS | 0.18% |
| 42 | COLL COLLEGIUM PHARMACEUTICAL | 0.16% |
| 43 | PAHC PHIBRO ANIMAL HEALTH CORP CLASS A | 0.15% |
| 44 | ALMS ALUMIS | 0.12% |
| 45 | AVLN AVALYN PHARMA INC | 0.11% |
| 46 | IHE USD CASH | 0.11% |
| 47 | WVE WAVE LIFE SCIENCES | 0.10% |
| 48 | EOLS EVOLUS INC | 0.09% |
| 49 | ARVN ARVINAS | 0.08% |
| 50 | PHAT PHATHOM PHARMACEUTICALS | 0.07% |
| 51 | CRMD CORMEDIX | 0.07% |
| 52 | BIOA BIOAGE LABS | 0.05% |
| 53 | EYPT EYEPOINT INC | 0.01% |
Sector breakdown
Pharmaceuticals99.9%
Cash and/or Derivatives0.1%
Country breakdown
United States100.0%
Distributions
| Date | Per unit |
|---|---|
| Sep 15, 2026 | $0.2789 |
| Jun 15, 2026 | $0.2848 |
| Mar 17, 2026 | $0.2845 |
| Dec 16, 2025 | $0.5853 |
| Sep 16, 2025 | $0.3124 |
| Jun 16, 2025 | $0.3065 |
| Mar 18, 2025 | $0.2917 |
| Dec 17, 2024 | $0.2108 |
| Sep 25, 2024 | $0.3589 |
| Jun 11, 2024 | $0.2940 |
| Mar 21, 2024 | $0.2750 |
| Dec 20, 2023 | $0.1347 |
| Sep 26, 2023 | $0.3007 |
| Jun 7, 2023 | $0.1967 |
| Mar 23, 2023 | $0.2240 |
| Dec 13, 2022 | $0.4457 |
| Sep 26, 2022 | $0.2949 |
| Jun 9, 2022 | $0.2390 |
| Mar 24, 2022 | $0.2647 |
| Dec 13, 2021 | $0.2633 |
| Sep 24, 2021 | $0.2773 |
| Jun 10, 2021 | $0.2403 |
| Mar 25, 2021 | $0.2117 |
| Dec 14, 2020 | $0.1753 |
| Sep 23, 2020 | $0.2363 |
| Jun 15, 2020 | $0.1047 |
| Mar 25, 2020 | $0.1957 |
| Dec 16, 2019 | $0.1717 |
| Sep 24, 2019 | $0.2098 |
| Jun 17, 2019 | $0.1783 |
| Mar 20, 2019 | $0.1857 |
| Dec 17, 2018 | $0.1168 |
| Sep 26, 2018 | $0.1321 |
| Jun 26, 2018 | $0.1628 |
| Mar 22, 2018 | $0.1767 |
| Dec 19, 2017 | $0.1242 |
| Sep 26, 2017 | $0.1498 |
| Jun 27, 2017 | $0.3061 |
| Mar 24, 2017 | $0.1193 |
| Dec 21, 2016 | $0.1127 |
Members of Congress who disclosed this ETF
| Member | Action | Amount band | Date |
|---|---|---|---|
| Bill Cassidy · Senate · R | Sell | $1K–$15K | Jan 31, 2018 |
| Bill Cassidy · Senate · R | Buy | $1K–$15K | Aug 27, 2015 |
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error